4//SEC Filing
Matsuda Masaru 4
Accession 0001787306-24-000083
CIK 0001787306other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 7:38 PM ET
Size
7.4 KB
Accession
0001787306-24-000083
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Sale
Common Stock
2024-05-28$9.01/sh−1,775$15,988→ 188,508 total - Award
Common Stock
2024-05-27+4,875→ 190,283 total
Footnotes (3)
- [F1]Represents performance stock units ("PSUs") initially granted on January 3, 2022 that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on May 27, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date.
- [F2]The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the reporting person's PSUs.
- [F3]The transaction was executed in multiple trades in prices ranging from $8.99 to $9.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001798679
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 7:38 PM ET
- Size
- 7.4 KB